Epoprostenol injection bulk supplier for pharma manufacturers

Epoprostenol Injection 1.5 mg/via; Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 1.5 mg/via;

Reference Brands: Flolan®(Us & Eu)

Epoprostenol infusion solution is a prostacyclin analogue that dilates pulmonary blood vessels, reducing blood pressure in PAH. It inhibits platelet aggregation, preventing blood clots. Benefits include improved exercise capacity, symptom relief, and enhanced quality of life in PAH patients, especially those with advanced disease.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Epoprostenol infusion solution, marketed as Flolan® in the US and EU, is approved for pulmonary arterial hypertension. Regulatory dossiers include extensive clinical data, manufacturing details, and safety profiles submitted to FDA and EMA, supporting its approval for continued use. The solution is administered via continuous IV infusion, with dosing tailored individually. These dossiers ensure high-quality standards and efficacy. For in-depth insights into regulatory submissions, dossier requirements, and market approvals, visit PharmaTradz, your trusted source for pharmaceutical regulatory updates and industry insights.

Epoprostenol Injection — third party manufacturing & bulk supply

Epoprostenol Injection 1.5 mg/via; is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Epoprostenol Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Epoprostenol Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Epoprostenol Injection →

Back to Listing

Frequently Asked Questions

Epoprostenol injection is listed as Injection in 1.5 mg/via;. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Epoprostenol injection is referenced against Flolan®(Us & Eu). Reference brands are shown for identification only and remain the property of their respective trademark owners.